Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | |
---|---|---|---|
2023 | |||
Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 Inhibitors Journal:Journal of the National Comprehensive Cancer Network | 1-Jun-2024 | ||
Risk of New-Onset Prostate Cancer for Metformin Versus Sulfonylurea Use in Type 2 Diabetes Mellitus: A Propensity Score-Matched Study Journal:JNCCN Journal of the National Comprehensive Cancer Network | 2022 | ||
Risk of New-Onset Prostate Cancer for Metformin Versus Sulfonylurea Use in Type 2 Diabetes Mellitus: A Propensity Score–Matched Study Journal:Journal of the National Comprehensive Cancer Network | 2022 | ||
2023 |